methylergonovine has been researched along with Complete Breech in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brustman, L; Ganz, E; Khalil, S; Kinsey, KE | 1 |
| Käch, O; Lüscher, KP | 1 |
2 other study(ies) available for methylergonovine and Complete Breech
| Article | Year |
|---|---|
Intraoperative coagulopathy during cesarean section as an unsuspected initial presentation of COVID-19: a case report.
Topics: Adult; Antifibrinolytic Agents; Betacoronavirus; Blood Coagulation Disorders; Blood Loss, Surgical; Breech Presentation; C-Reactive Protein; Cautery; Cesarean Section; Coronavirus Infections; COVID-19; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hemostasis, Surgical; Humans; International Normalized Ratio; Methylergonovine; Oligohydramnios; Oxytocics; Oxytocin; Pandemics; Platelet Count; Pneumonia, Viral; Pregnancy; Pregnancy Complications, Hematologic; Pregnancy Complications, Infectious; Prothrombin Time; SARS-CoV-2; Tranexamic Acid; Uterine Inertia | 2020 |
[Anesthesia in vaginal breech presentation].
Topics: Anesthesia, Local; Breech Presentation; Cesarean Section; Female; Humans; Labor Presentation; Methoxyflurane; Methylergonovine; Oxytocin; Pregnancy; Thiopental | 1980 |